English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The non-surgical treatment of the prostate carcinoma (PC) exist an increased acceptance of the patients. Prerequisite is however an appropriate monitoring as well as the possibility of the restaging (response). To date the inspection results after primary irradiation through the determination of the PSA-NADIR (“Nadir”, arabic = base point, deepest PSA value after therapy). After the ASTRO criteria, a recurrent tumor growth exist if a PSA increase of <1.5 ng/ml is detectable. The so-called Bounce phenomenon and the recurrent inflammatory reaction of the prostate tissue demarcate frequently the exact biochemical estimation of the PSA value. After the first hormone therapy of the recidivating prostate carcinoma, presently yet no exact PSA value is determined as a guideline.

Diffusion Weighted Imaging (DWI) at 3 Tesla MRI to Evaluate the Tumor Response of the Prostate Carcinoma after Radiation or Antiandrogen Therapy